Malcolm Hoffman
Stock Analyst at BMO Capital
(0.59)
# 4,341
Out of 5,134 analysts
15
Total ratings
33.3%
Success rate
-12.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Malcolm Hoffman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | Maintained: Buy | $34 | $16.48 | +106.37% | 8 | Nov 10, 2026 | |
| LBRX LB Pharmaceuticals | Reiterated: Buy | $54 | $45.04 | +19.89% | 3 | Nov 5, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $310 | $133.90 | +131.52% | 4 | Nov 2, 2026 |
Acadia Pharmaceuticals
Nov 10, 2026
Maintained: Buy
Price Target: $34
Current: $16.48
Upside: +106.37%
LB Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $54
Current: $45.04
Upside: +19.89%
Axsome Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $310
Current: $133.90
Upside: +131.52%